RESUMEN
The objective of the study was to determine the safety and efficacy of squaric acid dibutyl ester (SADBE) therapy on the treatment of recalcitrant warts in children. This retrospective chart review examined 72 patients treated using SADBE from July 2002 to December 2012. Patients were followed for 6 months to 11 years. Patients were treated at a pediatric dermatology outpatient clinic at the University of North Carolina at Chapel Hill. Seventy-two children with verrucae who failed initial treatment for warts were selected for the study. Full long-term follow-up was obtained in 48 patients. Four patients discontinued the use of SADBE because of adverse effects. The primary study outcome was efficacy of SADBE treatment. Adverse effects, dosages administered, type of wart, other cutaneous disease present, and level of immunosuppression were measured. Forty of 48 (83%) patients in whom treatment outcomes could be obtained reported complete resolution of their warts. Seventy percent of patients used a maximum concentration of 0.4% SADBE and 60% of patients reported no adverse effects. The majority of patients treated with SADBE reported complete resolution of warts. Most patients reported no adverse effects even while receiving doses as high as 2% daily. This study shows that SADBE is a safe and effective treatment for recalcitrant warts in children.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Ciclobutanos/uso terapéutico , Verrugas/tratamiento farmacológico , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
The dermatologic conditions that are most commonly encountered by nondermatologists are not well characterized, which can hamper efforts to train them in skin disease management. The purpose of this study was to identify the 20 most common dermatologic conditions encountered by nondermatologic specialties (ie, emergency medicine, family practice, general surgery, internal medicine, otolaryngology, pediatrics). Data from the National Ambulatory Medical Care Survey from 2001 to 2010 were analyzed to evaluate the dermatologic diagnoses made by each specialty during this time period. The most common skin conditions reported by dermatologists were compared to those reported by nondermatologists. Nondermatologists evaluated 52.9% of cutaneous diseases that presented in the outpatient setting. Among each nondermatologic specialty included in the study, only 6 to 10 of the top 20 conditions overlapped with the top 20 conditions reported by dermatologists. This study is a retrospective review of a large database and only included skin conditions that were diagnosed in an outpatient setting. The skin conditions that most frequently presented to nondermatologists differed considerably from those most commonly seen by dermatologists. Because dermatologists often are responsible for training nondermatologists in the diagnosis and management of skin disease, curriculum content should reflect these differences to enhance the efficacy of such training opportunities.
Asunto(s)
Dermatología/educación , Manejo de la Enfermedad , Enfermedades de la Piel/diagnóstico , Atención Ambulatoria/estadística & datos numéricos , Competencia Clínica , Medicina Familiar y Comunitaria/educación , Medicina Familiar y Comunitaria/normas , Cirugía General/educación , Cirugía General/normas , Encuestas de Atención de la Salud , Humanos , Evaluación de Necesidades , Pediatría/educación , Pediatría/normas , Mejoramiento de la CalidadRESUMEN
Depigmentation after the use of topical immune modulators is a rare but reported event. Herein we present what is to our knowledge the first case of vitiligo at a site of Candida antigen injection.
Asunto(s)
Antígenos Fúngicos/efectos adversos , Candida/inmunología , Liquen Escleroso y Atrófico/complicaciones , Vitíligo/etiología , Verrugas/tratamiento farmacológico , Antígenos Fúngicos/administración & dosificación , Niño , Crioterapia , Femenino , Fluorouracilo/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Vitíligo/inmunología , Verrugas/terapiaRESUMEN
PURPOSE: To enhance the learner's competence with knowledge of the clinical variants and management of psoriasis. TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care. OBJECTIVES: After participating in this educational activity, the participant should be better able to:1. Demonstrate knowledge of the types, symptoms, and diagnostic testing of psoriasis.2. Apply knowledge of psoriasis treatment to patient care scenarios. ABSTRACT: Psoriasis is an inflammatory skin condition that is associated with various comorbidities. To the wound care physician, the Koebner phenomenon is of importance, as any superficial trauma can induce psoriasis. Particularly, periwound and joints are particularly susceptible to flare-ups of this condition. This review highlights the epidemiology and treatment of psoriasis.
Asunto(s)
Psoriasis/diagnóstico , Psoriasis/terapia , Enfermedad Crónica , Diagnóstico Diferencial , Humanos , Psoriasis/complicaciones , Cicatrización de Heridas , Heridas y Lesiones/complicaciones , Heridas y Lesiones/terapiaRESUMEN
An unusual case of pigmented Bowen disease on the palm is presented.
Asunto(s)
Enfermedad de Bowen/diagnóstico , Errores Diagnósticos , Dermatosis de la Mano/etiología , Hiperpigmentación/etiología , Queratosis/etiología , Neoplasias Cutáneas/diagnóstico , Negro o Afroamericano , Enfermedad de Bowen/complicaciones , Humanos , Queratosis Seborreica/diagnóstico , Masculino , Persona de Mediana Edad , Neoplasias Cutáneas/complicacionesRESUMEN
Vitiligo is the most common cutaneous depigmentation disorder worldwide, yet little is known about specific risk factors for disease development. Using data from the Nurses' Health Study, a prospective cohort study of 51,337 white women, we examined the associations between (i) pigmentary traits and (ii) reactions to sun exposure and risk of incident vitiligo. Nurses' Health Study participants responded to a question about clinician-diagnosed vitiligo and year of diagnosis (2001 or before, 2002-2005, 2006-2009, 2010-2011, or 2012+). We used Cox proportional hazards regression models to estimate the multivariate-adjusted hazard ratios and 95% confidence intervals of incident vitiligo associated with exposures variables, adjusting for potential confounders. We documented 271 cases of incident vitiligo over 835,594 person-years. Vitiligo risk was higher in women who had at least one mole larger than 3 mm in diameter on their left arms (hazard ratio = 1.37, 95% confidence interval = 1.02-1.83). Additionally, vitiligo risk was higher among women with better tanning ability (hazard ratio = 2.59, 95% confidence interval = 1.21-5.54) and in women who experienced at least one blistering sunburn (hazard ratio = 2.17, 95% confidence interval = 1.15-4.10). In this study, upper extremity moles, a higher ability to achieve a tan, and history of a blistering sunburn were associated with a higher risk of developing vitiligo in a population of white women.
Asunto(s)
Pigmentación de la Piel/fisiología , Pigmentación de la Piel/efectos de la radiación , Luz Solar/efectos adversos , Vitíligo/epidemiología , Vitíligo/fisiopatología , Adulto , Factores de Edad , Anciano , Estudios de Cohortes , Femenino , Color del Cabello , Humanos , Incidencia , Persona de Mediana Edad , Nevo/epidemiología , Nevo/patología , Pronóstico , Modelos de Riesgos Proporcionales , Estudios Retrospectivos , Medición de Riesgo , Factores de Tiempo , Rayos Ultravioleta/efectos adversosRESUMEN
This contribution consolidates data on international pregnancy rating classifications, including the former US Food and Drug Administration (FDA), Swedish, and Australian classification systems, as well as the evidence-based medicine system, and discusses discrepancies among them. It reviews the new Pregnancy and Lactation Labeling Rule (PLLR) that replaced the former FDA labeling system with narrative-based labeling requirements. PLLR emphasizes on human data and highlights pregnancy exposure registry information. In this context, the review discusses important data on the safety of most medications used in the management of skin disease in pregnancy. There are also discussions of controversies relevant to the safety of certain dermatologic medications during gestation.
Asunto(s)
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Preparaciones Farmacéuticas/clasificación , Complicaciones del Embarazo/tratamiento farmacológico , Enfermedades de la Piel/tratamiento farmacológico , Corticoesteroides/efectos adversos , Antiinfecciosos/efectos adversos , Australia , Productos Biológicos/efectos adversos , Contraindicaciones , Etiquetado de Medicamentos/legislación & jurisprudencia , Medicina Basada en la Evidencia , Femenino , Humanos , Inmunosupresores/efectos adversos , Lactancia , Embarazo , Retinoides/efectos adversos , Suecia , Estados Unidos , United States Food and Drug AdministrationRESUMEN
OBJECT: A small percentage of cerebral aneurysms rupture, but when they do, the effects are devastating. Current management of unruptured aneurysms consists of surgery, endovascular treatment, or watchful waiting. If the biology of how aneurysms grow and rupture were better known, a novel drug could be developed to prevent unruptured aneurysms from rupturing. Ruptured cerebral aneurysms are characterized by inflammation-mediated wall remodeling. The authors studied the role of stromal cell-derived factor-1 (SDF-1) in inflammation-mediated wall remodeling in cerebral aneurysms. METHODS: Human aneurysms, murine carotid artery aneurysms, and murine intracranial aneurysms were studied using immunohistochemistry. Flow cytometry analysis was performed on blood from mice developing carotid or intracranial aneurysms. The effect of SDF-1 on endothelial cells and macrophages was studied by chemotaxis cell migration assay and capillary tube formation assay. Anti-SDF-1 blocking antibody was given to mice and compared with control (vehicle)-administered mice for its effects on the walls of carotid aneurysms and the development of intracranial aneurysms. RESULTS: Human aneurysms, murine carotid aneurysms, and murine intracranial aneurysms all expressed SDF-1, and mice with developing carotid or intracranial aneurysms had increased progenitor cells expressing CXCR4, the receptor for SDF-1 (p < 0.01 and p < 0.001, respectively). Human aneurysms and murine carotid aneurysms had endothelial cells, macrophages, and capillaries in the walls of the aneurysms, and the presence of capillaries in the walls of human aneurysms was associated with the presence of macrophages (p = 0.01). Stromal cell-derived factor-1 promoted endothelial cell and macrophage migration (p < 0.01 for each), and promoted capillary tube formation (p < 0.001). When mice were given anti-SDF-1 blocking antibody, there was a significant reduction in endothelial cells (p < 0.05), capillaries (p < 0.05), and cell proliferation (p < 0.05) in the aneurysm wall. Mice given anti-SDF-1 blocking antibody developed significantly fewer intracranial aneurysms (33% vs 89% in mice given control immunoglobulin G, respectively; p < 0.05). CONCLUSIONS: These data suggest SDF-1 is associated with angiogenesis and inflammatory cell migration and proliferation in the walls of aneurysms, and may have a role in the development of intracranial aneurysms.
Asunto(s)
Aneurisma/patología , Enfermedades de las Arterias Carótidas/patología , Movimiento Celular/efectos de los fármacos , Quimiocina CXCL12/farmacología , Neovascularización Patológica/patología , Aneurisma/metabolismo , Animales , Arterias Carótidas/efectos de los fármacos , Arterias Carótidas/metabolismo , Arterias Carótidas/patología , Enfermedades de las Arterias Carótidas/metabolismo , Proliferación Celular/efectos de los fármacos , Quimiocina CXCL12/metabolismo , Células Endoteliales/efectos de los fármacos , Humanos , Aneurisma Intracraneal/metabolismo , Aneurisma Intracraneal/patología , Ratones , Neovascularización Patológica/metabolismoRESUMEN
Inverse psoriasis is a disorder of intertriginous areas of the skin that can easily masquerade as candidal intertrigo. Candidal rashes are commonly encountered in primary care and typically respond promptly to therapy. When treatment fails, nonadherence to treatment and medication resistance often are suspected; however, the possibility of an incorrect diagnosis should also be entertained. This article presents the case of a patient with inverse psoriasis who was misdiagnosed with recurrent candidal intertrigo multiple times. The diagnosis and treatment of inverse psoriasis is reviewed, and other conditions that may be confused with Candida and inverse psoriasis, including bacterial intertrigo, tinea, and seborrheic dermatitis, are discussed. When confronted with a case of "resistant Candida," consideration of inverse psoriasis and other Candida mimics can allow physicians to diagnose and treat these conditions more effectively, avoiding the frustration experienced by our patient.
Asunto(s)
Candidiasis Cutánea/diagnóstico , Intertrigo/diagnóstico , Psoriasis/diagnóstico , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Intertrigo/etiología , Psoriasis/complicaciones , Resultado del TratamientoRESUMEN
BACKGROUND: Although there are several large-species animal models for saccular aneurysms, there is a need for a simple, reproducible saccular aneurysm model in mice. OBJECTIVE: To develop a murine saccular aneurysm model, which replicates key characteristics that occur in the formation of human cerebral aneurysms. METHODS: Elastase is applied extravascularly to the right common carotid artery. We induced saccular aneurysm formation by our method in C57BL/6 mice (n = 30). Aneurysms and control arteries (left common carotid arteries) were harvested at 1 week, 2 weeks, and 3 weeks postinjury (n = 10 for each time point), measured, and stained for elastin content. To demonstrate BMP-derived cell recruitment to the aneurysms, bone marrow from UBC-gfp transgenic mice was transplanted into irradiated C57BL/6 recipients to create C57BL/6.gfp chimeras. Additionally, bone marrow from DsRed transgenic mice was transplanted into irradiated C57BL/6 recipients to create C57BL/6.DsRed chimeras, and bone marrow from B5/EGFP transgenic mice was transplanted into irradiated FVB recipients to create FVB.gfp chimeras. The elastase injury or sham operations were performed in the C57BL/6.gfp, C57BL/6.DsRed, and FVB.gfp chimeras. Aneurysms and sham vessels were harvested at 3 weeks and examined for BMP-derived cell recruitment. Additionally, aneurysms were stained for matrix metalloproteinase-9, which is overexpressed in human cerebral aneurysm tissue. RESULTS: Aneurysms consistently demonstrated significant loss of elastin in the vessel wall and had significantly larger diameters than control vessels (591 +/- 238 microm vs 328 +/- 61 microm; P = .003 for aneurysms 3 weeks postinjury). Aneurysms from C57BL/6.gfp, FVB.gfp, and C57BL/6.DsRed chimeras consistently revealed significant BMP-derived cell recruitment in the aneurysm wall that was not seen in sham-operated vessels nor in control left common carotid arteries. Aneurysms demonstrated overexpression of matrix metalloproteinase-9. CONCLUSION: We describe a novel murine elastase saccular aneurysm model that replicates the histopathology and BMP-derived cell-mediated processes that will be a valuable instrument for studying the cell-mediated processes in cerebral aneurysm formation.